When should Homocystein be retested?

Homocysteine should be retested approximately 8–12 weeks after initiating therapy (e.g., folic acid, vitamin B12, B6) to assess treatment response. For elevated baseline levels without intervention, retesting after 3–6 months is reasonable to evaluate natural variation. Routine population screening is not recommended by major guidelines (e.g., USPSTF) because lowering homocysteine has not been proven to reduce cardiovascular events in randomized trials. Retesting decisions should be individualized based on clinical context: renal impairment, thyroid disorders, medication use (e.g., methotrexate), and the reason for initial testing. Caveat: a single elevated value may reflect temporary factors (diet, smoking, coffee); consider controlling these before retesting. Evidence is based on clinical practice guidelines and observational studies.